33 results
425
EQRX
EQRx, Inc.
23 Oct 23
Business combination disclosure
6:13am
was initiated at the 200 mg dose level.
The exposure-to-target engagement relationship in preclinical studies predicts greater than 90 percent average cross
DEFM14A
EQRX
EQRx, Inc.
29 Sep 23
Proxy related to merger
4:38pm
discussed the potential engagement of a financial advisor to assist in a review of strategic alternatives that might be available to EQRx.
On October 27 … discussed the engagement of Goldman Sachs as its financial advisor in connection with the review of strategic alternatives and potential strategic
DEF 14A
EQRX
EQRx, Inc.
12 Aug 22
Definitive proxy
4:05pm
;
managing the selection, engagement and qualifications of a qualified firm to serve as the independent registered public accounting firm to audit
POS AM
EQRX
EQRx, Inc.
23 Mar 22
Prospectus update (post-effective amendment)
6:30pm
the basis of our “Global Buyers Club” — a collection of customers with aligned incentives and deep engagement. These collaborations are rooted … and engagement between a manufacturer and a payer is unprecedented in the biopharma industry. Our goal is to rebuild trust with payers, providers and healthcare
10-K
2021 FY
EX-10.12
EQRX
EQRx, Inc.
23 Mar 22
Annual report
4:43pm
with others prior to my engagement by the Company:
No inventions or improvements
See below:
Additional sheets attached
The following is a list of all patents and patent applications in which I have been named as an inventor:
None
See below:
10-K
53j4uh rb3
23 Mar 22
Annual report
4:43pm
424B3
z69kbv0k 64nnb
23 Dec 21
Prospectus supplement
5:24pm
424B3
0zbtuh3ydw95mvo7f
1 Dec 21
Prospectus supplement
4:43pm
S-4/A
EX-10.15
jrqe0325gv2dbzxl
1 Oct 21
Registration of securities issued in business combination transactions (amended)
9:52pm
S-4/A
EX-10.14
dly90 cwjp8euwvuq
1 Oct 21
Registration of securities issued in business combination transactions (amended)
9:52pm
S-4/A
e93ugurrrzytj1n94no
1 Oct 21
Registration of securities issued in business combination transactions (amended)
9:52pm
S-4
t4tcm 79mr
25 Aug 21
Registration of securities issued in business combination transactions
3:21pm
8-K
EX-99.2
oma6s36i7q2u7ju
6 Aug 21
EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III
7:04am
8-K
EX-2.1
3l75w8tpfc4t
6 Aug 21
EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III
7:04am
8-K
EX-99.1
atkj3
6 Aug 21
EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III
7:04am